Related Experiment Video
Updated: Apr 5, 2026

12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
8.2K
Prescribing for Australians living with dementia: study protocol using the Delphi technique
Amy Page1, Kathleen Potter1, Rhonda Clifford1
1School of Medicine and Pharmacology, University of Western Australia, Perth, Australia.
BMJ Open
|August 13, 2015
Summary
This study will develop expert consensus on medication prescribing for Australians with dementia. The goal is to create clear criteria for safe and appropriate medicine use in this population.
Area of Science:
- Geriatric Therapeutics
- Dementia Care
- Pharmacology
Background:
- Medication management for individuals with dementia presents significant challenges.
- Careful consideration is required for both continuing existing and initiating new medications in people with dementia.
- There is a need for explicit prescribing criteria tailored to this population in Australia.
Purpose of the Study:
- To elicit expert opinion on appropriate medication use for people living with dementia in Australia.
- To achieve consensus among geriatric therapeutics experts on prescribing criteria.
- To develop a consensus-based list of explicit prescribing criteria for medication use in dementia.
Main Methods:
- A Delphi technique will be employed with an interdisciplinary panel of Australian geriatric therapeutics experts (minimum 10 participants).
- An iterative, anonymous, multistaged approach with controlled feedback will be used.
- Qualitative analysis of Round 1 questionnaire results will inform a Round 2 questionnaire using a five-point Likert scale, repeating until consensus is reached.
Main Results:
- Consensus-based explicit prescribing criteria for medication use in adults aged 65 years and above with dementia will be developed.
- The study will provide a framework for optimizing pharmacotherapy in this vulnerable population.
Conclusions:
- The developed criteria will support evidence-based prescribing practices for people with dementia in Australia.
- This research aims to improve medication safety and efficacy, contributing to better patient outcomes.
- Findings will be disseminated through peer-reviewed publications and conference presentations.
Related Concept Videos
Drug Dosing: Geriatric Patients
357
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
357
Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
Dosage Regimens: Designs and Approaches
477
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
477
Pharmacodynamics in Geriatric Patients: Effects of Age
325
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
325
Dementia
709
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
709
Ethical Dilemmas II
2.9K
Resolving an ethical dilemma in healthcare involves a systematic approach that considers every aspect of the issue, respecting both the patient's needs and values and the healthcare professional's ethical obligations. Here are potential steps to resolve an ethical dilemma:
2.9K
